"H Bj\u00F6rk" . "160" . "K E Andersson" . "Intravesical oxybutynin for neurogenic bladder dysfunction: less systemic side effects due to reduced first pass metabolism"@nl . "9720583" . . "scientific article published on 01 September 1998"@en . "im September 1998 ver\u00F6ffentlichter wissenschaftlicher Artikel"@de . "1998-09-01T00:00:00Z"^^ . "Intravesical oxybutynin for neurogenic bladder dysfunction: less systemic side effects due to reduced first pass metabolism"@en . . . . "Intravesical oxybutynin for neurogenic bladder dysfunction: less systemic side effects due to reduced first pass metabolism"@en . . . "Intravesical oxybutynin for neurogenic bladder dysfunction: less systemic side effects due to reduced first pass metabolism"@en . . . . . . "\u043D\u0430\u0443\u043A\u043E\u0432\u0430 \u0441\u0442\u0430\u0442\u0442\u044F, \u043E\u043F\u0443\u0431\u043B\u0456\u043A\u043E\u0432\u0430\u043D\u0430 \u0443 \u0432\u0435\u0440\u0435\u0441\u043D\u0456 1998"@uk . . . "3 Pt 1" . . "C Verpoorten" . "Intravesical oxybutynin for neurogenic bladder dysfunction: less systemic side effects due to reduced first pass metabolism"@en . . . "P Casaer" . "wetenschappelijk artikel"@nl . "10.1097/00005392-199809010-00084" . . "K Waldeck" . "Intravesical oxybutynin for neurogenic bladder dysfunction: less systemic side effects due to reduced first pass metabolism"@nl . "Intravesical oxybutynin for neurogenic bladder dysfunction: less systemic side effects due to reduced first pass metabolism"@nl . "art\u00EDculu cient\u00EDficu espubliz\u00E1u en setiembre de 1998"@ast . . . . "892-896" . . . "G Buyse" .